680 filings
Page 20 of 34
6-K
cfm8qsue41iw zzhg
28 Sep 17
RedHill Biopharma to Announce Top-Line Results from BEKINDA® 12 mg Phase II Study for IBS-D on October 3rd, 2017
12:00am
6-K
tgzztv3zv9i luhpj
18 Sep 17
RedHill Biopharma Receives Notice of Allowance for a New U.S. Patent Covering its Combination Therapy for Hard-to-Treat Cancers
12:00am
6-K
577vvez7ftmg wfm
18 Sep 17
RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
12:00am
6-K
1rew487qc
13 Sep 17
Current report (foreign)
12:00am
6-K
vvsvj68xy9rzyt7
7 Sep 17
RedHill Biopharma to Present at the 10th Annual BioPharm America International Partnering Conference
12:00am
6-K
dvzqzujtor
31 Aug 17
RedHill Biopharma to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
12:00am
6-K
u0ize4m
17 Aug 17
RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules
12:00am
6-K
0wbj1x22wn yp8r8p
10 Aug 17
RedHill Biopharma Provides 2017 Semi-Annual Business Update
12:00am
6-K
s8s74p nkfwvxh5
31 Jul 17
RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn’s Disease
12:00am
6-K
qf8r3b8wh
25 Jul 17
Current report (foreign)
12:00am
6-K
g2zc36hcrlabvfjm 45h
18 Jul 17
Current report (foreign)
12:00am
6-K
vdeo34o
17 Jul 17
RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D
12:00am
6-K
miza2vbuc3l5vu24um
12 Jul 17
RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease
12:00am
6-K
no6fcesi1n hn0e68u
19 Jun 17
RedHill Biopharma to Host Conference Call on Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis
12:00am
6-K
8v2zpc7x
15 Jun 17
RedHill Biopharma Announces Confirmatory Phase III Study Initiated with RHB-105 (TALICIA™) for H. pylori Infection
12:00am
6-K
xwp51 5tmlb5s0o
14 Jun 17
RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA® for Acute Gastroenteritis
12:00am
6-K
5zjspx5rdjtx6
13 Jun 17
Current report (foreign)
12:00am
6-K
5fr41wdw3s
6 Jun 17
RedHill Biopharma to Present at the 2017 BIO International Convention
12:00am
6-K
rfo1i2t hah
11 May 17
Current report (foreign)
12:00am
6-K
pbx j6636nhez
4 May 17
RedHill Biopharma Announces Poster Presentation of the Positive RHB-105 Phase III Results for H. pylori Infection at Digestive Disease Week 2017
12:00am